🔬
Foundation Sciences · Biochemistry
Cell Cycle and Checkpoints
G1/S, G2/M and spindle checkpoints regulated by cyclins, CDKs, p53 and Rb.
📌 Learning Objectives
- Describe the key principles of cell cycle and checkpoints.
- Explain the clinical relevance of cell cycle and checkpoints.
- Recognise common conditions linked to cell cycle and checkpoints in MLA-style scenarios.
📋 Overview
G1/S, G2/M and spindle checkpoints regulated by cyclins, CDKs, p53 and Rb. This topic integrates with pathology, pharmacology and clinical medicine and is frequently tested in UK medical school exams and the MLA.
🔬 Basic Science
G1/S, G2/M and spindle checkpoints regulated by cyclins, CDKs, p53 and Rb. Detailed mechanisms, regulation and molecular interactions underpin both normal physiology and disease.
🏥 Clinical Relevance
Li-Fraumeni (p53), retinoblastoma (Rb), targeted oncology.
🧪 Investigations
Relevant laboratory tests, imaging or histological examination are used as appropriate to the clinical context.
💊 Management
Management is condition-specific; principles include addressing the underlying biochemical/structural derangement, supportive care and targeted therapy where available.
Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.
MLA High-Yield Notes & Quick Revision ⌄
High-yield topic for the UK MLA — frequently appears in SBA questions linking biochemistry concepts to clinical presentations and management decisions.
Applying biomedical science to clinical practice
Diagnosis and investigation
Pathophysiology of common conditions
- G1/S, G2/M and spindle checkpoints regulated by cyclins, CDKs, p53 and Rb.
Exam Pearls ⌄
⭐ High Yield
Rb sequesters E2F; phosphorylation by cyclin D-CDK4/6 releases it
p53 'guardian of the genome' arrests G1 via p21
CDK4/6 inhibitors (palbociclib) in HR+ breast cancer
💡 Clinical Pearl
: Li-Fraumeni (p53), retinoblastoma (Rb), targeted oncology.
⚠️ Exam Tip — Common Mistakes
Confusing cell cycle and checkpoints with related but distinct mechanisms.
Memorising pathways without linking to clinical disease.
Key Facts ⌄
Rb sequesters E2F; phosphorylation by cyclin D-CDK4/6 releases it
p53 'guardian of the genome' arrests G1 via p21
CDK4/6 inhibitors (palbociclib) in HR+ breast cancer
References ⌄
- BMJ Best Practice
- Robbins Basic Pathology
- Lippincott Illustrated Reviews: Biochemistry
- Wheater's Functional Histology
- NICE guidance where applicable.
Further Resources
Medical Portfolio & Career Development
Build a professional portfolio website for applications, audits, teaching, research and career progression.
CVtoWebsite.com →